- Diabetic Foot Ulcers
- Grade 0
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Grade 5
- Pressure Ulcers
- Stage 1
- Stage 2
- Stage 3
- Stage 4
Diabetic Foot Ulcers And Pressure Ulcers Market size was valued at 4,609.2 million in 2021 and is expected to reach 7,747.0 million by 2028, at a CAGR of 7.7% during the forecast period 2022 to 2028. Diabetic foot ulcers are the full-thickness wounds present below the ankle in diabetic patients. The risk factors for the diabetic foot ulcers include poor blood circulation, neuropathy, and insufficiently well controlled diabetes are among others. Pressure ulcers or bedsores are injuries to skin and underlying tissue, caused by the prolonged pressure on skin. Pressure ulcers are majorly affect the persons with paralysis, old age, illness, and frailty.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence diabetes and neuropathic diseases such as paralysis surge the global diabetic foot ulcers and pressure ulcers market. Moreover, rise in R&D expenditure for the innovation of newer therapeutics, government initiations to control the diabetes and chronic wounds, grow in incidence of paralysis and other chronic diseases reduces the mobility, unhealthy lifestyle, and increase in geriatric population are anticipated to propel the diabetic foot ulcers and pressure ulcers market over the forecast years. However, high cost of treatment, dearth of skilled professionals in underdeveloped countries, and limited number of biologicals for the treatment are restrain the growth of global market.
Geographically, global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market has a lucrative growth attributed to rise in prevalence of diabetic foot ulcers and pressure ulcers due to increase in the incidence of diabetes, advancements in the treatment procedures, and increase in healthcare expenditure are bolster the market. Europe market is poised to grow attributed to increase in the prevalence of diabetes and neurological disorders, high adoption of newer treatment procedures, and rise in disposable income are fuel the market. Asia Pacific market has prominent share attributed to rise in geriatric population in India, China, and Japan, large patient pool, and entry of market players into Asia Pacific region are bolster the market.
Latin America
Europe
Asia Pacific
Middle East
North America
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
[urltag url='request-table-of-content']